UOX and hyperuricemia: In summary, we generated a CRISPR/Cas9-based Uox-KO Wistar rat model that exhibited persistent and stable hyperuricemia, suggesting it may be an effective and reliable tool to study the mechanisms underlying hyperuricemia-related diseases and their potential treatments.